Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels

Reinhold Feldmann (), Ulrike Och, Lisa Sophie Beckmann, Josef Weglage and Frank Rutsch
Additional contact information
Reinhold Feldmann: Department of General Pediatrics, Münster University Children’s Hospital, 48149 Münster, Germany
Ulrike Och: Department of General Pediatrics, Münster University Children’s Hospital, 48149 Münster, Germany
Lisa Sophie Beckmann: Department of General Pediatrics, Münster University Children’s Hospital, 48149 Münster, Germany
Josef Weglage: Children’s Healthcare Center “Haus Walstedde”, 48317 Drensteinfurt, Germany
Frank Rutsch: Department of General Pediatrics, Münster University Children’s Hospital, 48149 Münster, Germany

IJERPH, 2024, vol. 21, issue 4, 1-9

Abstract: Background: We assessed the relationship between the cognitive development of children and adolescents with phenylketonuria (PKU) and fluctuations in peripheral phenylalanine (Phe) levels. Methods: We examined the neurocognitive performance of 33 children and adolescents with early treated PKU, of whom 18 were treated with sapropterin dihydrochloride, and 15 were on a classic diet. For 26 weeks, patients were assessed weekly for their blood phenylalanine (Phe) levels. Phe levels were analyzed for fluctuations indicated by the individual standard deviation. Fluctuations were compared to the standard deviation of 26 Phe level measurements before the study interval. We also assessed the concurrent IQ of the patients. This was repeated at one-, two-, and seven-year intervals. Results: Full-scale IQ in patients treated with a classic diet did not change within the follow-up. In patients treated with Sapropterin dihydrochloride, however, there was a considerable gain in full-scale IQ. This was particularly true if blood Phe fluctuations increased in patients of this treatment group. Conclusions: Sapropterin dihydrochloride enhances Phe tolerance in patients with PKU. Increasing blood Phe fluctuations following enhanced Phe tolerance may indicate that the treatment not only allows patients to relax their Phe-restricted diet but also may support cognitive development in patients.

Keywords: PKU; phenylalanine; blood Phe variations; FSIQ; gain in function (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/21/4/431/pdf (application/pdf)
https://www.mdpi.com/1660-4601/21/4/431/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:21:y:2024:i:4:p:431-:d:1369097

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().